Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer. (4th May 2022)

Record Type:: Journal Article
Title:: Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer. (4th May 2022)
Main Title:: Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer
Authors:: Claessens, Anouk K. M.
Busschbach, Jan J. V.
Ramaekers, Bram L. T.
Erdkamp, Frans L. G.
Bouma, Jeanette M.
van Leeuwen-Stok, A. Elise
Tjan-Heijnen, Vivianne C. G.
Bos, Monique E. M. M.
Abstract:
Is Part Of:: Acta oncologica. Volume 61:Number 5(2022)
Journal:: Acta oncologica
Issue:: Volume 61:Number 5(2022)
Issue Display:: Volume 61, Issue 5 (2022)
Year:: 2022
Volume:: 61
Issue:: 5
Issue Sort Value:: 2022-0061-0005-0000
Page Start:: 619
Page End:: 624
Publication Date:: 2022-05-04
Subjects:: Oncology -- Periodicals
Cancer -- Treatment -- Periodicals
616.992
Journal URLs:: http://informahealthcare.com/loi/onc ↗
http://informahealthcare.com ↗
DOI:: 10.1080/0284186X.2022.2033832 ↗
Languages:: English
ISSNs:: 0284-186X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0641.705000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21421.xml